ANRIL plays a role in atherosclerosis via the epigenetic silencing of CDKN2A/B through the recruitment of polycomb repressive complexes, leading to inappropriate growth of vascular smooth muscle cells. The gene discussed is CDKN2B-AS1; the disease is atherosclerosis.